BlackRock
SQZ

BlackRock’s SQZ Biotechnologies Company SQZ Stock Holding History

BlackRock’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-64,677
Closed -$17.5K – 5635
2023
Q2 		$17.5K Sell
64,677
-58,132
-47% -$33K ﹤0.01% 5213
2023
Q1 		$68.8K Buy
122,809
+618
+0.5% +$455 ﹤0.01% 5050
2022
Q4 		$90.4K Sell
122,191
-156,013
-56% -$341K ﹤0.01% 5072
2022
Q3 		$635K Sell
278,204
-8,433
-3% -$25.3K ﹤0.01% 4646
2022
Q2 		$910K Sell
286,637
-1,094,818
-79% -$3.94M ﹤0.01% 4571
2022
Q1 		$6.64M Sell
1,381,455
-32,415
-2% -$206K ﹤0.01% 3798
2021
Q4 		$12.6M Buy
1,413,870
+163,780
+13% +$2.01M ﹤0.01% 3529
2021
Q3 		$18M Buy
1,250,090
+34,139
+3% +$463K ﹤0.01% 3358
2021
Q2 		$17.6M Buy
1,215,951
+983,747
+424% +$12.9M ﹤0.01% 3381
2021
Q1 		$3.18M Buy
232,204
+21,750
+10% +$442K ﹤0.01% 4141
2020
Q4 		$6.1M Buy
+210,454
New +$5.37M ﹤0.01% 3616

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock's SQZ Position: Q3 2023 in Review

BlackRock sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 64,677 shares — an estimated $17.5K sold.

BlackRock first reported a position in SQZ in Q4 2020 and held it in 11 quarters. The position peaked at $18M in Q3 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • BlackRock reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • BlackRock sold 64,677 SQZ Biotechnologies Company shares in Q3 2023, an estimated $17.5K.
  • BlackRock first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 11 quarters.
  • BlackRock's SQZ Biotechnologies Company position peaked at $18M in Q3 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.